Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intellipharmaceutics International Inc IPCIQ

Healthcare Biotechnology
Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this... see more

Bullboard (GREY:IPCIQ)

View:
Prev 1 2 3 4 5 6 7 8 9 Next
Comment by Fonzieeon Feb 17, 2020 5:59pm

RE:RE:RE:RE:Pill deserved the no vote but it's an easy fix.

if you watched the conference live on the internet and paid attention, it told you everything about the pill and why it is easier to snort and provides a more instant high effect. You should do your ...more  
317
Discussion
Comment by bigkaganon Feb 14, 2020 4:03pm

RE:RE:RE:RE:Pill deserved the no vote but it's an easy fix.

is it a coincidence that IPCI is up 10% exactly a month since the unfortunate AdCom meeting? I don't think so. FDA could have already rejected it if it really wanted, the longer there is no ...more  
239
Discussion
Comment by bigkaganon Feb 11, 2020 3:06pm

RE:RE:RE:Pill deserved the no vote but it's an easy fix.

it's still better than the rest of the Oxy pills, at least they tried to do something. And how do you know it, have you tried to snort it? They haven't released the damn thing yet
148
Discussion
Comment by Fonzieeon Feb 10, 2020 9:18pm

RE:RE:Pill deserved the no vote but it's an easy fix.

i know more than you bigkagan, Sorry you lost all your stack and are trying to pump something when there is nothing. Hence your the only one on this board. They messed up making pill to easy to snort ...more  
162
Discussion
Comment by bigkaganon Feb 03, 2020 3:15pm

RE:RE:RE:RE:RE:RE:Advisor commitee vote and PDF

how come no lawsuits against IPCI after the AdCom rejection like it was with CORV, maybe lawyers are smelling an FDA approval? hee
166
Discussion
Comment by bigkaganon Jan 31, 2020 11:07am

RE:RE:RE:RE:RE:Advisor commitee vote and PDF

wow, up 10% on a good volume, maybe it's not over yet, ha
151
Discussion
Comment by bigkaganon Jan 27, 2020 1:08pm

RE:RE:RE:RE:Advisor commitee vote and PDF

looks like FDA isn't in a hurry to reject Aximiris, they don't even have a date, usually they have a date called PDUFA but not in this case. If and when they reject Aximiris it will look very ...more  
199
Discussion
Comment by bigkaganon Jan 22, 2020 5:43pm

RE:RE:RE:Advisor commitee vote and PDF

FDA only agrees with AdCom in 80% of the cases - so there is no a better candidate than IPCI to be in the 20% when FDA disagrees with the AdCom and I think today's 30% rise in IPCI shows that some ...more  
164
Discussion
Comment by Priatomaon Jan 22, 2020 4:21pm

RE:RE:Advisor commitee vote and PDF

BIGKAGAN, You pick a good point. if FDA consider Ad.Com vote only putting aside scientifica evaluation they should ban some of the existing Opioid products too. I see Some of the existing products in ...more  
149
Discussion
Comment by bigkaganon Jan 21, 2020 4:07pm

RE:Advisor commitee vote and PDF

I'm with you - the AdCom people rejected the Aximiris on purely emotional and moralistic grounds but Oxydone is not banned in the US. If FDA doesn't want any more opioid drugs it should have ...more  
204
Discussion
Comment by Priatomaon Jan 21, 2020 1:37pm

RE:Advisor commitee vote and PDF

I also think FDA need to act according to Scintific eveluation NOT on emotional basis.
146
Discussion
Post by Priatomaon Jan 21, 2020 1:34pm

Advisor commitee vote and PDF

After rejection of IPCI oxycodone in 2017 the company fulfill each and every  requirments those were asked by FDA. IPCI perforemd catagory 2 and 3 studies moreover anything-anytime FDA asked the ...more  
298
Discussion
Comment by bigkaganon Jan 20, 2020 12:15am

RE:Pill deserved the no vote but it's an easy fix.

you don't know nothing, IPCI has already done what FDA wanted them to do, it's impossible to improve the pill any further, FDA has to approve it as it is
190
Discussion
Post by Fonzieeon Jan 19, 2020 8:38pm

Pill deserved the no vote but it's an easy fix.

The pill its easier to crush and snort which is the main way of abuse. Also it has a more intense rapid onset when snorted so it is ideal for the ABUSER! That's why it failed. Ipci has nailed down ...more  
343
Discussion
Comment by bigkaganon Jan 19, 2020 6:25pm

RE:RE:RE:RE:Did you notice?

there could be a conflict between FDA and the AdCom because a year ago FDA practically assured IPCI that if it tweeks the oral and nasal safety features the approval is assured - now if FDA rejects ...more  
193
Discussion
Prev 1 2 3 4 5 6 7 8 9 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities